Multitask joint learning with graph autoencoders for predicting potential MiRNA-drug associations
The occurrence of many diseases is associated with miRNA abnormalities. Predicting potential drug-miRNA associations is of great importance for both disease treatment and new drug discovery. Most computation-based approaches learn one task at a time, ignoring the information contained in other tasks...
Gespeichert in:
Veröffentlicht in: | Artificial intelligence in medicine 2023-11, Vol.145, p.102665-102665, Article 102665 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The occurrence of many diseases is associated with miRNA abnormalities. Predicting potential drug-miRNA associations is of great importance for both disease treatment and new drug discovery. Most computation-based approaches learn one task at a time, ignoring the information contained in other tasks in the same domain. Multitask learning can effectively enhance the prediction performance of a single task by extending the valid information of related tasks. In this paper, we presented a multitask joint learning framework (MTJL) with a graph autoencoder for predicting the associations between drugs and miRNAs. First, we combined multiple pieces of information to construct a high-quality similarity network of both drugs and miRNAs and then used a graph autoencoder (GAE) to learn their embedding representations separately. Second, to further improve the embedding quality of drugs, we added an auxiliary task to classify drugs using the learned representations. Finally, the embedding representations of drugs and miRNAs were linearly transformed to obtain the predictive association scores between them. A comparison with other state-of-the-art models shows that MTJL has the best prediction performance, and ablation experiments show that the auxiliary task can enhance the embedding quality and improve the robustness of the model. In addition, we show that MTJL has high utility in predicting potential associations between drugs and miRNAs by conducting two case studies.
•MTJL is an end-to-end model and uses joint loss to maximize the feature extraction capability of the model.•MTJL utilizes multi-task joint learning to greatly improve its own robustness and predictive ability.•We shared the drug embedding across the different tasks, thus fully combining the domain information from both tasks.•Our experiments demonstrate that MTJL outperforms other state-of-the-art models and has good practicality. |
---|---|
ISSN: | 0933-3657 1873-2860 |
DOI: | 10.1016/j.artmed.2023.102665 |